Reduced retinal transduction and enhanced transgene-directed immunogenicity with intravitreal delivery of rAAV following posterior vitrectomy in dogs
Ryan F. Boyd(Michigan State University), Joshua T. Bartoe(Michigan State University), Thomas J. Conlon(Adelson Foundation), Simon M. Petersen‐Jones(Michigan State University), András M. Komáromy(University of Pennsylvania), Dodd G. Sledge(Michigan State University), Ingeborg M. Langohr(Michigan State University), William W. Hauswirth(University of Florida), Kirsten Erger(University of Florida), Sanford L. Boye(University of Florida)
Cited by 37
Related Papers
Treatment of Leber Congenital Amaurosis Due to <i>RPE65</i> Mutations by Ocular Subretinal Injection of Adeno-Associated Virus Gene Vector: Short-Term Results of a Phase I Trial
|Human Gene Therapy|2008|950
Recombinant Adeno-Associated Virus Serotype 9 Leads to Preferential Cardiac Transduction In Vivo
|Circulation Research|2006|400
Mutational Analysis of the Adeno-Associated Virus Type 2 (AAV2) Capsid Gene and Construction of AAV2 Vectors with Altered Tropism
|Journal of Virology|2000|392
Sustained transgene expression despite T lymphocyte responses in a clinical trial of rAAV1-AAT gene therapy
|Proceedings of the National Academy of Sciences|2009|322